| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $38.5M | -11.2% |
| Cost of Revenue | $23.6M | +17.4% |
| Gross Profit | $14.9M | -35.9% |
| R&D Expense | $58.7M | +8.3% |
| SG&A Expense | $49.1M | +17.4% |
| Operating Income | -$103.8M | -25.8% |
| Pre-tax Income | -$124.2M | -16.5% |
| Income Tax | $961K | -50.1% |
| Net Income | -$125.1M | -15.4% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.1M | +42.4% |
| Short-term Investments | $2.6M | -96.0% |
| Accounts Receivable | $6.3M | +17.8% |
| Inventory | $22.0M | +0.1% |
| Current Assets | $101.8M | -29.3% |
| Total Assets | $194.0M | -11.5% |
| Current Liabilities | $32.8M | -44.2% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$119.0M | -53.4% |
| Capital Expenditures | $2.9M | -32.8% |
| Investing Cash Flow | $44.1M | +1.4% |
| Financing Cash Flow | $87.6M | +9.2% |
| Free Cash Flow | -$121.9M | -49.0% |
| Long-term Debt |
| $233.3M |
| +60.9% |
| Total Liabilities | $338.1M | +36.2% |
| Stockholders' Equity | -$144.1M | -396.2% |